GSK plc GLAXF:OTCPK

RT Quote | Exchange | USD
Last | 05/17/22 EDT
21.60UNCH (UNCH)
Volume
51
52 week range
18.18 - 23.47
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close21.60
  • 52 Week High23.47
  • 52 Week High Date01/18/22
  • 52 Week Low18.18
  • 52 Week Low Date09/29/21

Key Stats

  • Market Cap111,414.21M
  • Shares Out5,083.9M
  • 10 Day Average Volume1,719
  • Dividend-
  • Dividend Yield-
  • Beta0.63
  • YTD % Change-1.37

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close21.60
  • 52 Week High23.47
  • 52 Week High Date01/18/22
  • 52 Week Low18.18
  • 52 Week Low Date09/29/21
  • Market Cap111,414.21M
  • Shares Out5,083.9M
  • 10 Day Average Volume1,719
  • Dividend-
  • Dividend Yield-
  • Beta0.63
  • YTD % Change-1.37

RATIOS/PROFITABILITY

  • EPS (TTM)1.34
  • P/E (TTM)16.12
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/27/2022(est)
  • Ex Div Date02/24/2022
  • Div Amount23.00
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a...
Jonathan Symonds CBE
Independent Non-Executive Chairman of the Board
Emma Walmsley
Chief Executive Officer, Executive Director
Iain Mackay
Chief Financial Officer, Executive Director
Address
G S K House, 980 Great West Road
Brentford
TW8 9GS
United Kingdom